about
Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rateNaphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPsAcute oxidative stress is associated with cell proliferation in the mouse liver.Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line.Organ-specific roles of CYP1A1 during detoxication of dietary benzo[a]pyrene.Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse lineEstrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.Gene expression changes during the development of acute lung injury: role of transforming growth factor beta.Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences--Cyp1 knockout mouse lines as a paradigm.Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model.Balance between Estrogens and Proinflammatory Cytokines Regulates Chemokine Production Involved in Thymic Germinal Center Formation.Central role of interferon-beta in thymic events leading to myasthenia gravis.Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.AIRE: a missing link to explain female susceptibility to autoimmune diseases.Thymus involvement in early-onset myasthenia gravis.An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype
P50
Q28288804-41B21A25-16F0-4FCC-A0FF-C2EF32854624Q28504444-2EF4F306-75CC-4C54-815A-9F0EB7A5FC63Q33247814-DF9DD1BD-DF42-4988-8656-C39EAD1B6EA5Q33263715-93A28DF6-F283-4DD4-97B0-A195EA337692Q34028183-D48A38FC-7ACF-4116-869C-C06B82CC3EDFQ36014555-239E7873-10FA-4D28-85CE-FBB2649CCB89Q36737968-46A97E38-B784-471C-9FCF-3251490FEA0FQ37282679-4E128FD3-20AA-4C6D-9A9D-7D9E503176BDQ37422752-CFB1C8A1-4EB6-4CFA-A31C-24425FA9C069Q37730809-B90C31BF-F92D-4E61-BACC-A342B161C915Q41368509-4D855ADC-8844-458B-B625-5A635513E206Q42244993-D4BA3707-6B38-4A4D-9499-7417157DB5F3Q44316843-60A84D17-87A7-447B-94F3-10F55C6C6A4FQ46560571-E949CBB2-3F77-47EE-88D2-AE6EDFA1AD98Q47227251-1B2BB98D-CBC7-41F4-ABD6-EEECFD22619CQ47846806-824DB231-0C73-4781-A5FC-AA72CCE97758Q50190538-11613D73-06B2-4303-AAEE-332473C3B47DQ58003128-2B8C1C61-2B09-4352-948D-D0DD6BB63F62
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nadine Dragin
@ast
Nadine Dragin
@en
Nadine Dragin
@es
Nadine Dragin
@nl
Nadine Dragin
@sl
type
label
Nadine Dragin
@ast
Nadine Dragin
@en
Nadine Dragin
@es
Nadine Dragin
@nl
Nadine Dragin
@sl
prefLabel
Nadine Dragin
@ast
Nadine Dragin
@en
Nadine Dragin
@es
Nadine Dragin
@nl
Nadine Dragin
@sl
P106
P31
P496
0000-0002-5250-322X